CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRSP Price/Volume Stats
| Current price | $52.73 | 52-week high | $63.68 |
| Prev. close | $56.42 | 52-week low | $30.04 |
| Day low | $52.33 | Volume | 3,116,800 |
| Day high | $56.87 | Avg. volume | 2,439,174 |
| 50-day MA | $42.80 | Dividend yield | N/A |
| 200-day MA | $43.47 | Market Cap | 4.55B |
CRSP Stock Price Chart Interactive Chart >
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
CRSP Price Returns
| 1-mo | 26.82% |
| 3-mo | 39.61% |
| 6-mo | 30.10% |
| 1-year | -15.97% |
| 3-year | -36.77% |
| 5-year | -42.90% |
| YTD | 33.97% |
| 2024 | -37.12% |
| 2023 | 54.00% |
| 2022 | -46.36% |
| 2021 | -50.51% |
| 2020 | 151.39% |
Continue Researching CRSP
Here are a few links from around the web to help you further your research on CRISPR Therapeutics AG's stock as an investment opportunity:CRISPR Therapeutics AG (CRSP) Stock Price | Nasdaq
CRISPR Therapeutics AG (CRSP) Stock Quote, History and News - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...